6550-14-571-2501
Monoclonal Anti-B Blood Grouping Serum
6550145712501 145712501 72102
INC: 47564 Monoclonal Anti-B Blood Grouping Serum
Managed by France
NSN Created on 6 Mar 2012
Data Last Changed
January 2023
January 2023
NATO Update Count
1
1
NATO Data Quality

Marketplace 6550-14-571-2501
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6550-14-571-2501 5+ Documents (More...)

https//www.nsnlookup.com
/fsg-65/fsc-6550/fr
/fsg-65/fsc-6550/fr
6550-14-571-2501 Monoclonal Anti-B Blood Grouping Serum
RQST NE Updated Every Day 6550-14-571-2501 RQST Updated Every Day 6550-14-571-2501 RQST NE Related Documents
6550-14-571-2501 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
Day 6550-14-571-2501 RQST NE Related Documents 6550-14-571-2501 5+ Documents ( More... ) https//www.nsnlookup.com
6550-14-571-2501 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
Day 6550-14-571-2501 RQST NE Related Documents 6550-14-571-2501 5+ Documents ( More... ) https//www.nsnlookup.com

https//www.nsnlookup.com
/fsg-65/fsc-6550/us
/fsg-65/fsc-6550/us
6550-01-504-1811 Monoclonal Anti-B Blood Grouping Serum
www.nsnlookup.com /fsg-65/fsc-6550/us 6550-01-504-1811 Monoclonal Anti-B Blood Grouping Serum 6550-14-571-2501
6550-14-571-2500 6550-01-504-1811 https https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
65/fsc-6550/us 6550-01-504-1811 Anti-B Blood Grouping Serum Serum 577 -2301 6550-19-002-4256 6550-14-571-2501
6550-14-571-2500 6550-01-504-1811 https https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
65/fsc-6550/us 6550-01-504-1811 Anti-B Blood Grouping Serum Serum 577 -2301 6550-19-002-4256 6550-14-571-2501

https//www.nsnlookup.com
/fsg-65/fsc-6550/fr
/fsg-65/fsc-6550/fr
6550-14-577-2276 Monoclonal Anti-B Blood Grouping Serum
Blood Grouping Serum Grouping Serum Blood Grouping Serum 6550-14-577-2276 6550-27-007-9179 Serum 6550-14-571-2501
65/fsc-6550/fr 6550-14-571-2500 6550-14-577-2276 https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
fsg-65/fsc-6550/fr 6550-14-577-2276 Blood Grouping Serum www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
65/fsc-6550/fr 6550-14-571-2500 6550-14-577-2276 https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
fsg-65/fsc-6550/fr 6550-14-577-2276 Blood Grouping Serum www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501

https//www.nsnlookup.com
/fsg-65/fsc-6550/uk
/fsg-65/fsc-6550/uk
6550-99-212-1631 Monoclonal Anti-B Blood Grouping Serum
Grouping Serum Grouping Serum 6550-99-212-1631 https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
Monoclonal Anti-B Blood Grouping Serum Grouping Serum Serum -002-4256 6550-14-571-2501 https//www.nsnlookup.com
212-1631 https//www.nsnlookup.com Blood Grouping Serum www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
Monoclonal Anti-B Blood Grouping Serum Grouping Serum Serum -002-4256 6550-14-571-2501 https//www.nsnlookup.com
212-1631 https//www.nsnlookup.com Blood Grouping Serum www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501

https//www.nsnlookup.com
/fsg-65/fsc-6550/br
/fsg-65/fsc-6550/br
6550-19-002-4256 Monoclonal Anti-B Blood Grouping Serum
www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2500 Monoclonal Anti-B Blood Grouping Serum https// Serum 6550-14-571-2501
www.nsnlookup.com /fsg-65/fsc-6550/br 6550-19-002-4256 https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
Monoclonal Anti-B Blood Grouping Serum 6550-14-571-2501 65/fsc-6550/us 6550-01-504-1811 Anti-B
www.nsnlookup.com /fsg-65/fsc-6550/br 6550-19-002-4256 https//www.nsnlookup.com /fsg-65/fsc-6550/fr 6550-14-571-2501
Monoclonal Anti-B Blood Grouping Serum 6550-14-571-2501 65/fsc-6550/us 6550-01-504-1811 Anti-B
Restrictions 6550-14-571-2501
End Users 6550-14-571-2501
- France (ZF)
Approved Sources 6550-14-571-2501
- Part Number
- Manufacturer
- Status
- 72102
- Manufacturer
- FAGT7 - Diagast (Active)
- Primary Buy
- Primary Buy
Similar Supply Items to 6550-14-571-2501

















